Deleting Malignant B Cells With Second-Generation Anti-CD20 Antibodies
J Clin Oncol
.
2018 Aug 1;36(22):2323-2325.
doi: 10.1200/JCO.2018.78.7390.
Epub 2018 Jun 12.
Authors
Josh Sopp
1
,
Mark S Cragg
1
Affiliation
1
Josh Sopp and Mark S. Cragg, University of Southampton, Southampton, United Kingdom.
PMID:
29894272
DOI:
10.1200/JCO.2018.78.7390
No abstract available
Publication types
Comment
MeSH terms
Antibodies, Monoclonal, Humanized
B-Lymphocytes
Bendamustine Hydrochloride
Humans
Lymphoma, Non-Hodgkin*
Rituximab
Substances
Antibodies, Monoclonal, Humanized
Rituximab
Bendamustine Hydrochloride
obinutuzumab
Grants and funding
24721/CRUK_/Cancer Research UK/United Kingdom